Astrana Health (NASDAQ:ASTH) Coverage Initiated at Needham & Company LLC

Research analysts at Needham & Company LLC assumed coverage on shares of Astrana Health (NASDAQ:ASTH) in a research note issued on Friday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $28.00 price target on the stock. Needham & Company LLC’s price objective suggests a potential upside of 19.30% from the company’s current price.

Other equities research analysts have also recently issued research reports about the company. Barclays decreased their target price on Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research note on Monday, November 24th. TD Cowen reduced their price objective on shares of Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a research report on Monday, November 10th. BTIG Research lowered their target price on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a report on Friday, November 7th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 8th. Finally, Jefferies Financial Group restated a “buy” rating on shares of Astrana Health in a research note on Tuesday, November 25th. Eight equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $41.33.

Astrana Health Price Performance

Shares of ASTH opened at $23.47 on Friday. The firm has a market capitalization of $1.32 billion, a price-to-earnings ratio of 123.53, a PEG ratio of 1.41 and a beta of 0.86. The firm’s fifty day simple moving average is $26.99 and its 200-day simple moving average is $26.77. Astrana Health has a twelve month low of $20.12 and a twelve month high of $39.97. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share for the quarter. The company had revenue of $317.00 million for the quarter. Astrana Health had a return on equity of 1.26% and a net margin of 0.33%. Equities analysts forecast that Astrana Health will post 1.15 EPS for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

Several institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in Astrana Health by 4.5% during the 1st quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company’s stock worth $151,918,000 after acquiring an additional 213,033 shares during the period. 325 Capital LLC lifted its holdings in shares of Astrana Health by 34.6% during the third quarter. 325 Capital LLC now owns 1,193,953 shares of the company’s stock worth $33,849,000 after purchasing an additional 307,037 shares during the period. SteelPeak Wealth LLC grew its position in Astrana Health by 7.8% in the 3rd quarter. SteelPeak Wealth LLC now owns 579,937 shares of the company’s stock valued at $16,441,000 after buying an additional 41,761 shares during the last quarter. Jacobs Levy Equity Management Inc. boosted its holdings in shares of Astrana Health by 19.2% in the third quarter. Jacobs Levy Equity Management Inc. now owns 500,527 shares of the company’s stock valued at $14,190,000 after acquiring an additional 80,465 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Astrana Health by 6.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company’s stock worth $15,490,000 after acquiring an additional 28,200 shares during the period. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.